Literature DB >> 19248125

Work disability in systemic lupus erythematosus.

Ali M Al Dhanhani1, Monique A M Gignac, Jiandong Su, Paul R Fortin.   

Abstract

OBJECTIVE: To determine the prevalence, accrual over time, and risk factors of work disability in patients with systemic lupus erythematosus (SLE).
METHODS: We studied 432 patients from an inception cohort. Work disability was measured from a single self-report question. Data were prospectively collected and included sociodemographic information, clinical lupus features including activity (Systemic Lupus Erythematosus Disease Activity Index 2000 update [SLEDAI-2K]), damage (Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index), and organ involvement, as well as health status (Short Form 36 [SF-36]), comorbidity, and medication use. Student's t-test and Wilcoxon's rank sum test were used to compare continuous variables and chi-square tests were used for dichotomous variables. Descriptive survival curves of time to work disability were presented. Bivariate and multivariate logistic regressions were used to describe the relationships between clinically relevant factors and work disability.
RESULTS: Of 432 patients, 88% were women and 73% were white. Within the first year of diagnosis, 47% of patients were employed, 7% had a disability, and 7% were on sick leave. Overall, work disability was found in 98 (23%) patients. Risk factors for work disability found in the multivariate regression analysis were younger age at diagnosis, less education, fibromyalgia, hypertension, higher first-visit SLEDAI-2K score, and lower first-visit SF-36 score.
CONCLUSION: Work disability is frequent in patients with SLE, with a cumulative prevalence of 23%. Work disability was associated with a complex array of health factors, including comorbidity, physical and mental health limitations, and clinical features of lupus, that warrant increased attention in future research.

Entities:  

Mesh:

Year:  2009        PMID: 19248125     DOI: 10.1002/art.24347

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

1.  Fatigue in systemic lupus erythematosus.

Authors:  Grace E Ahn; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2012-04-01

Review 2.  Critical Appraisal of the Quality of Literature Evaluating Psychometric Properties of Arthritis Work Outcome Assessments: A Systematic Review.

Authors:  Rawan Alheresh; Molly Vaughan; Michael P LaValley; Wendy Coster; Julie J Keysor
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-07-27       Impact factor: 4.794

Review 3.  Exploring the diversity of conceptualizations of work (dis)ability: a scoping review of published definitions.

Authors:  Valérie Lederer; Patrick Loisel; Michèle Rivard; François Champagne
Journal:  J Occup Rehabil       Date:  2014-06

4.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

5.  An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL.

Authors:  Jin-Shei Lai; Jennifer L Beaumont; Sally E Jensen; Karen Kaiser; David L Van Brunt; Amy H Kao; Shih-Yin Chen
Journal:  Clin Rheumatol       Date:  2016-11-15       Impact factor: 2.980

Review 6.  Pitfalls and opportunities in measuring patient outcomes in lupus.

Authors:  Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

Review 7.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

8.  Impact of early systemic lupus erythematosus on work disability-results from the Finnish nationwide register 2000-2007.

Authors:  Pia Elfving; Kari Puolakka; Vappu Rantalaiho; Hannu Kautiainen; Lauri J Virta; Oili Kaipiainen-Seppänen
Journal:  Clin Rheumatol       Date:  2018-03-14       Impact factor: 2.980

Review 9.  [Overcoming disease in systemic lupus erythematosus].

Authors:  M Schneider; M Haupt
Journal:  Z Rheumatol       Date:  2015-09       Impact factor: 1.372

10.  Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.

Authors:  So-Yeon Park; Young Bin Joo; Jeeseon Shim; Yoon-Kyoung Sung; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2015-08-09       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.